AbbVie’s blood cancer drug meets late-stage trial goals
AbbVie said its drug for a type of blood cancer met the main goals of a late-stage trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.